US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
Officials of the Union Health Ministry, along with DCGI held a discussion with the representatives of Gilead Sciences to prepare a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
Strides Pharma to conduct trials in India for potential COVID-19 drug
The Bengaluru-based company has received approval from the Drug Controller General of India to conduct human studies of…
NovaLead Pharma to conduct clinical trials for repurposed drug for COVID-19
The drug, code-named NLP21, is in human use for several years for its original approved usage without any side effects of concern
CDSCO observes lower supply of 15 drugs used for COVID-19 treatment
Asks drug manufacturers associations to ensure adequate production, supply and availability of these 15 drugs
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung…
Approval is based on the SENSCIS study which showed Nintedanib slows the loss of pulmonary function in people living with systemic…
CDSCO issues recommendations to lift export restrictions on paracetamol APIs
The letter states that six major manufacturers may be allowed to export up to 50 per cent of their monthly operating capacity in a…
874 pharma units in Gujarat working at 80 per cent capacity: Dr Hemant Koshia
The State has 130 US FDA approved and 628 WHO GMP complied units
CDSCO to assess issues in the procurement and prices of APIs
This step is being taken by the authorities after media reports and representation by different pharma associations raise concerns…
NPPA allows six paracetamol APIS manufacturers to export 2000 MT
Permissions have been granted to Farmson Pharmaceuticals, Meghmani LLP, Sri Krishna Pharmaceutical, Granules India, Bharat…
CSIR identifies top 25 drugs/drug candidates for repurposing
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs